$8.3M
sold in all offerings
Trace Biosciences Inc. is a corporation based in Beaverton, OR in the Biotechnology industry group. From August 12, 2026 to August 12, 2026 it filed 1 private fundraising filing for 1 offering and reported $8.3 million sold in all.
Updated October 10, 2026 · newest filing Aug 12, 2026
Amount sold
$8.3M
All offerings, newest filing of each
Offered
$16.2M
Total amount sought
Offerings
1
1 filing with amendments
Newest offering
$8.3M
Sold, first filed Aug 12, 2026
Investors
19
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- Beaverton, OR
- Industry group
- Biotechnology
- Listed
- No
- First filing
- August 12, 2026
- Newest filing
- August 12, 2026
- Exemptions
- 506(b)
Offerings
1 offering, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | $8.3M | $16.2M | 19 | - | 506(b) | Equity |
Filing history
1 filing, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Aug 12, 2026 | New offering | $8.3M | $16.2M | 19 |
Related pages
Questions and answers
How much has Trace Biosciences Inc. raised in private offerings?
$8.3 million sold in 1 private offering reported from Aug 12, 2026 to Aug 12, 2026, counting each offering once at its newest filing.
When did Trace Biosciences Inc. last file about a private offering?
August 12, 2026. Its newest offering reported $8.3 million sold of $16.2 million offered to 19 investors.
Which exemption does Trace Biosciences Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is Trace Biosciences Inc. a listed company?
No ticker is linked to this issuer, so it is private or no longer listed.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.